| 14902 | N | 022048 | 001 | TRIAMCINOLONE ACETONIDE | INJECTABLE;INTRAVITREAL | INJECTABLE | INTRAVITREAL | TRIESENCE | NOVARTIS | 40MG/ML (40MG/ML) | | [] | 2007-11-29 | Nov 29, 2007 | No | Yes | Yes | RX | NOVARTIS PHARMACEUTICALS CORP | 88d3ece453dcc5f1b0fa56a9e79202a62ccf2c4f5bd24b7c803bf1d04eb897c8 |
| 14903 | A | 207324 | 001 | CARBOPLATIN | INJECTABLE;IV (INFUSION) | INJECTABLE | IV (INFUSION) | CARBOPLATIN | GLAND PHARMA LTD | 50MG/5ML (10MG/ML) | AP | ["AP"] | 2017-02-15 | Feb 15, 2017 | No | No | No | RX | GLAND PHARMA LTD | f88ee8514b4ef0f6d717906e62debbf309f6491dc7cbc7edd88c2965d57ade15 |
| 14904 | A | 079197 | 001 | PANTOPRAZOLE SODIUM | INJECTABLE;IV (INFUSION) | INJECTABLE | IV (INFUSION) | PANTOPRAZOLE SODIUM | AKORN | EQ 40MG BASE/VIAL | AP | ["AP"] | 2012-11-08 | Nov 8, 2012 | No | No | No | RX | AKORN OPERATING CO LLC | ecfdab89fef05f30f1ddcd4e2771994d3094decfe0c7500b95e0058a38168a19 |
| 14905 | A | 205675 | 001 | PANTOPRAZOLE SODIUM | INJECTABLE;IV (INFUSION) | INJECTABLE | IV (INFUSION) | PANTOPRAZOLE SODIUM | AUROBINDO PHARMA LTD | EQ 40MG BASE/VIAL | AP | ["AP"] | 2016-03-30 | Mar 30, 2016 | No | No | No | RX | AUROBINDO PHARMA LTD | 6958f3b578f6b03dc969a82558768b16799d3dfa7a6dfd1f3d86b05ad18ffa05 |
| 14906 | A | 208580 | 001 | PANTOPRAZOLE SODIUM | INJECTABLE;IV (INFUSION) | INJECTABLE | IV (INFUSION) | PANTOPRAZOLE SODIUM | MYLAN LABS LTD | EQ 40MG BASE/VIAL | | [] | 2018-05-04 | May 4, 2018 | No | No | No | DISCN | MYLAN LABORATORIES LTD | c7d096d5a170480d73305035e433ba2879c53cc80a77140a7ce8a5f47ee17f7e |
| 14907 | A | 090296 | 001 | PANTOPRAZOLE SODIUM | INJECTABLE;IV (INFUSION) | INJECTABLE | IV (INFUSION) | PANTOPRAZOLE SODIUM | SANDOZ INC | EQ 40MG BASE/VIAL | AP | ["AP"] | 2015-07-14 | Jul 14, 2015 | No | No | No | RX | SANDOZ INC | ff3f913da004b37eb5c37961621ef26b9c4ab2d2b86ecd6db73e7089d176950d |
| 14908 | A | 077674 | 001 | PANTOPRAZOLE SODIUM | INJECTABLE;IV (INFUSION) | INJECTABLE | IV (INFUSION) | PANTOPRAZOLE SODIUM | SUN PHARM | EQ 40MG BASE/VIAL | AP | ["AP"] | 2019-08-19 | Aug 19, 2019 | No | No | No | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | 3b9aa2599cf3f40450c286cce99d47a72d43717d046a415e8d3311c5e3f9b2a4 |
| 14909 | N | 020988 | 001 | PANTOPRAZOLE SODIUM | INJECTABLE;IV (INFUSION) | INJECTABLE | IV (INFUSION) | PROTONIX IV | WYETH PHARMS | EQ 40MG BASE/VIAL | AP | ["AP"] | 2001-03-22 | Mar 22, 2001 | No | Yes | Yes | RX | WYETH PHARMACEUTICALS LLC | 3ca2ab6092d232e435491961bc078f2955480e5b6103ceb83c560547bda3cdea |
| 14910 | N | 021272 | 001 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | REMODULIN | UNITED THERAP | 1MG/ML | AP | ["AP"] | 2002-05-21 | May 21, 2002 | No | Yes | Yes | RX | UNITED THERAPEUTICS CORP | eb4b88366bea6bbe8f1b99860da8acea7413494407ace88098285ed207ca082c |
| 14911 | N | 021272 | 002 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | REMODULIN | UNITED THERAP | 2.5MG/ML | AP | ["AP"] | 2002-05-21 | May 21, 2002 | No | Yes | Yes | RX | UNITED THERAPEUTICS CORP | 702358efc94e5256fef2e8dcf9eedc1b5e13472a20076d0501a29bea4a517731 |
| 14912 | N | 021272 | 003 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | REMODULIN | UNITED THERAP | 5MG/ML | AP | ["AP"] | 2002-05-21 | May 21, 2002 | No | Yes | Yes | RX | UNITED THERAPEUTICS CORP | 218191f543a9aedcad2d52e6902fe5638eaafb0ebcdbc8fece718d04f5049233 |
| 14913 | N | 021272 | 004 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | REMODULIN | UNITED THERAP | 10MG/ML | AP | ["AP"] | 2002-05-21 | May 21, 2002 | No | Yes | Yes | RX | UNITED THERAPEUTICS CORP | 1606098c54eeb3e442a5fc16df83ad58f3f158d445a0296016fda6ce5e89593c |
| 14914 | A | 211574 | 001 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | ALEMBIC GLOBAL | 1MG/ML | AP | ["AP"] | 2021-02-11 | Feb 11, 2021 | No | No | No | RX | ALEMBIC GLOBAL HOLDING SA | 542a249ab6e77599ed172424f0f06c7449b6dad9e9ac6eea2ab6e1186d6a9e63 |
| 14915 | A | 211574 | 002 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | ALEMBIC GLOBAL | 2.5MG/ML | AP | ["AP"] | 2021-02-11 | Feb 11, 2021 | No | No | No | RX | ALEMBIC GLOBAL HOLDING SA | f924ba7e3520aa47669fa5a278917427efa55769debad70f745ab6529611aac5 |
| 14916 | A | 211574 | 003 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | ALEMBIC GLOBAL | 5MG/ML | AP | ["AP"] | 2021-02-11 | Feb 11, 2021 | No | No | No | RX | ALEMBIC GLOBAL HOLDING SA | 74e5fd4e1838cbe9ee8b8b2c5edd8eda643da21dae813971abc3c793dee66b7a |
| 14917 | A | 211574 | 004 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | ALEMBIC GLOBAL | 10MG/ML | AP | ["AP"] | 2021-02-11 | Feb 11, 2021 | No | No | No | RX | ALEMBIC GLOBAL HOLDING SA | d3553ed0be3684b72a4f96450169f8966f7e86260d94e9785e3052bb1b6afd3f |
| 14918 | A | 210214 | 001 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | DR REDDYS | 1MG/ML | | [] | 2020-05-22 | May 22, 2020 | No | No | No | DISCN | DR REDDYS LABORATORIES LTD | 0e62d85371fe3e43a4ac604029f402806985e4c3719c20fc48b8abe819831306 |
| 14919 | A | 210214 | 002 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | DR REDDYS | 2.5MG/ML | | [] | 2020-05-22 | May 22, 2020 | No | No | No | DISCN | DR REDDYS LABORATORIES LTD | b950c95b7496e5ae4af40480a08902dc93a748f0c6a4bb8acac49bb508cf7f48 |
| 14920 | A | 210214 | 003 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | DR REDDYS | 5MG/ML | | [] | 2020-05-22 | May 22, 2020 | No | No | No | DISCN | DR REDDYS LABORATORIES LTD | c90b1fbbf52925d1c6308d2e11fc2a2ef1fb6eb39fd061ba97889c47c09e64ea |
| 14921 | A | 210214 | 004 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | DR REDDYS | 10MG/ML | | [] | 2020-05-22 | May 22, 2020 | No | No | No | DISCN | DR REDDYS LABORATORIES LTD | e6bf022c12f6a4bfac5a5b219ab82f60bd54f33cf38cde0c4ecd803b165e4818 |
| 14922 | A | 209382 | 001 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | PAR STERILE PRODUCTS | 1MG/ML | AP | ["AP"] | 2019-09-24 | Sep 24, 2019 | No | No | No | RX | PAR STERILE PRODUCTS LLC | 7724f64730d70eed7cc629544514dec1566380e19fb9912860cc85bf6ba7bab9 |
| 14923 | A | 209382 | 002 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | PAR STERILE PRODUCTS | 2.5MG/ML | AP | ["AP"] | 2019-09-24 | Sep 24, 2019 | No | No | No | RX | PAR STERILE PRODUCTS LLC | 2ce2df60901f0ff427416a6d93ddee5229008ffb85b05467c45961c0707a7dca |
| 14924 | A | 209382 | 003 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | PAR STERILE PRODUCTS | 5MG/ML | AP | ["AP"] | 2019-09-24 | Sep 24, 2019 | No | No | No | RX | PAR STERILE PRODUCTS LLC | 081b6db6fe0890c6a40f576e36fed99cd2d80d91371d9f392c160ea801bbfcc1 |
| 14925 | A | 209382 | 004 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | PAR STERILE PRODUCTS | 10MG/ML | AP | ["AP"] | 2019-09-24 | Sep 24, 2019 | No | No | No | RX | PAR STERILE PRODUCTS LLC | 8b6d25a13b0f70e03ae718efb638ab9d19fb4e87bcdeac7a73bf4283f5ebcd7d |
| 14926 | A | 203649 | 001 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | SANDOZ INC | 1MG/ML | AP | ["AP"] | 2017-11-30 | Nov 30, 2017 | No | No | No | RX | SANDOZ INC | 9c80d1338c44fe4aa2bee6e1d72d0576e45f876ef99f301a3d593749d3d1e81a |
| 14927 | A | 203649 | 002 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | SANDOZ INC | 2.5MG/ML | AP | ["AP"] | 2017-11-30 | Nov 30, 2017 | No | No | No | RX | SANDOZ INC | 05986fff50934ca9d35851b0af29d3c574aa8575e67e62e535b4df436d94ca38 |
| 14928 | A | 203649 | 003 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | SANDOZ INC | 5MG/ML | AP | ["AP"] | 2017-11-30 | Nov 30, 2017 | No | No | No | RX | SANDOZ INC | df7eb2dc269d25f9713824d11d3e75b86e6acc72477547af4fde678f874d846e |
| 14929 | A | 203649 | 004 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | SANDOZ INC | 10MG/ML | AP | ["AP"] | 2017-11-30 | Nov 30, 2017 | No | No | No | RX | SANDOZ INC | 340bf13146fe94136e5ca4d9eb559314cf5a0e54a10a5c23f49a2e85e55658c0 |
| 14930 | A | 206648 | 001 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | TEVA PHARMS USA | 1MG/ML | AP | ["AP"] | 2019-09-26 | Sep 26, 2019 | No | No | No | RX | TEVA PHARMACEUTICALS USA | b87c9eb8e77eef5e773f7ce2d9755c895fe07986c76b24f1986419a6d7b2bafe |
| 14931 | A | 206648 | 002 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | TEVA PHARMS USA | 2.5MG/ML | AP | ["AP"] | 2019-09-26 | Sep 26, 2019 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 300e195c773a931f86b63d29160323c946a7113a45b4b79564ea400ce0d75b7a |
| 14932 | A | 206648 | 003 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | TEVA PHARMS USA | 5MG/ML | AP | ["AP"] | 2019-09-26 | Sep 26, 2019 | No | No | No | RX | TEVA PHARMACEUTICALS USA | fe75a602eec4eedd40dc2c4ca24ca400db971bf535adb55eae9c583c17080ba6 |
| 14933 | A | 206648 | 004 | TREPROSTINIL | INJECTABLE;IV (INFUSION), SUBCUTANEOUS | INJECTABLE | IV (INFUSION), SUBCUTANEOUS | TREPROSTINIL | TEVA PHARMS USA | 10MG/ML | AP | ["AP"] | 2019-09-26 | Sep 26, 2019 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 908b3f9f379b8c4a4cdf3ed8b1010ceceda9513d6394aa89c160f6c42e5bed56 |
| 14934 | A | 209087 | 001 | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;SPINAL | INJECTABLE | SPINAL | BUPIVACAINE HYDROCHLORIDE | B BRAUN MEDICAL INC | 0.75% | AP | ["AP"] | 2019-04-02 | Apr 2, 2019 | No | No | No | RX | B BRAUN MEDICAL INC | b0adb15ab285b346f6581f894e1bbeefebbe28f431c61cb63a67238fb9c1fe00 |
| 14935 | A | 207266 | 001 | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;SPINAL | INJECTABLE | SPINAL | BUPIVACAINE HYDROCHLORIDE | BAXTER HLTHCARE CORP | 0.75% | AP | ["AP"] | 2016-07-25 | Jul 25, 2016 | No | No | No | RX | BAXTER HEALTHCARE CORP | 791672cf8b40e286525699c1f85222be482535cba8aea3dbb658a04496306d0b |
| 14936 | A | 071810 | 001 | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;SPINAL | INJECTABLE | SPINAL | BUPIVACAINE HYDROCHLORIDE | HOSPIRA | 0.75% | AP | ["AP"] | 1987-12-11 | Dec 11, 1987 | No | No | No | RX | HOSPIRA INC | bd165d1c26c780cf1a44d0ce5e41f4eb082cc4aa6b4fbb2fc3ba2500b22df6d7 |
| 14937 | A | 212822 | 001 | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;SPINAL | INJECTABLE | SPINAL | BUPIVACAINE HYDROCHLORIDE | HUONS | 0.75% | AP | ["AP"] | 2019-12-30 | Dec 30, 2019 | No | No | No | RX | HUONS CO LTD | 79229982d226aaf437e528f6d8ec5cb776d39fd9a1ff8d7c3c09de98c3496415 |
| 14938 | A | 083914 | 001 | LIDOCAINE HYDROCHLORIDE | INJECTABLE;SPINAL | INJECTABLE | SPINAL | LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% | HOSPIRA | 5% | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | Yes | RX | HOSPIRA INC | 24d1a195cb5a2e49b9348e1955a5c91c22e5abb13159d65dc50e38f972556c90 |
| 14939 | N | 018692 | 001 | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;SPINAL | INJECTABLE | SPINAL | MARCAINE | HOSPIRA | 0.75% | AP | ["AP"] | 1984-05-04 | May 4, 1984 | No | Yes | Yes | RX | HOSPIRA INC | d503920ab11780468607b0ed5a80fc34f62f0d95088d8a8e4f9de8a67e51c58b |
| 14940 | A | 071202 | 001 | BUPIVACAINE HYDROCHLORIDE | INJECTABLE;SPINAL | INJECTABLE | SPINAL | SENSORCAINE | FRESENIUS KABI USA | 0.75% | | [] | 1987-04-15 | Apr 15, 1987 | No | No | No | DISCN | FRESENIUS KABI USA LLC | 547fc28c4b0316d1998dc70e875540fefe4384279a555ea413768402005127e2 |
| 14941 | N | 016297 | 001 | LIDOCAINE HYDROCHLORIDE | INJECTABLE;SPINAL | INJECTABLE | SPINAL | XYLOCAINE 1.5% W/ DEXTROSE 7.5% | FRESENIUS KABI USA | 1.5% | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | FRESENIUS KABI USA LLC | 9e75b6e9cdebd4dcbd2c5c5509c2348ac0950b7794dbba985147e4989db7db58 |
| 14942 | N | 010496 | 002 | LIDOCAINE HYDROCHLORIDE | INJECTABLE;SPINAL | INJECTABLE | SPINAL | XYLOCAINE 5% W/ GLUCOSE 7.5% | ASTRAZENECA | 5% | | [] | 1982-07-07 | Jul 7, 1982 | No | No | No | DISCN | ASTRAZENECA LP | 94f5d651460eb1d0f4a97c28911fef686b7c0a45f66a1805da32ebd0b224d15b |
| 14943 | N | 022377 | 001 | SUMATRIPTAN SUCCINATE | INJECTABLE;SUBCUTANEOUS | INJECTABLE | SUBCUTANEOUS | ALSUMA | MERIDIAN MEDCL | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | | [] | 2010-06-29 | Jun 29, 2010 | No | No | No | DISCN | MERIDIAN MEDICAL TECHNOLOGIES INC SUB KING PHARMACEUTICALS INC | 261602dbe63b5ecaeff262ca257a77aeef2a5639f15be75a61daaf344bf565f6 |
| 14944 | N | 021264 | 001 | APOMORPHINE HYDROCHLORIDE | INJECTABLE;SUBCUTANEOUS | INJECTABLE | SUBCUTANEOUS | APOKYN | MDD US | 20MG/2ML (10MG/ML) | | [] | 2004-04-20 | Apr 20, 2004 | No | No | No | DISCN | MDD US OPERATIONS LLC | 082fda31377957c57ff868087fc0299310f0999b2f99e0fd2d1f080001aa3d16 |
| 14945 | N | 021264 | 002 | APOMORPHINE HYDROCHLORIDE | INJECTABLE;SUBCUTANEOUS | INJECTABLE | SUBCUTANEOUS | APOKYN | MDD US | 30MG/3ML (10MG/ML) | | [] | 2004-04-20 | Apr 20, 2004 | No | Yes | Yes | RX | MDD US OPERATIONS LLC | f45865784af4df99fc4eb3d85e86c6ed178e3f846894635c2a69387b3687a575 |
| 14946 | N | 021345 | 001 | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | INJECTABLE | SUBCUTANEOUS | ARIXTRA | MYLAN IRELAND LTD | 2.5MG/0.5ML | AP | ["AP"] | 2001-12-07 | Dec 7, 2001 | No | Yes | Yes | RX | MYLAN IRELAND LTD | b0e614eb8e833eea21821a7b517575759010c32375d43d8d665b1d4403b3f485 |
| 14947 | N | 021345 | 002 | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | INJECTABLE | SUBCUTANEOUS | ARIXTRA | MYLAN IRELAND LTD | 5MG/0.4ML | AP | ["AP"] | 2004-05-28 | May 28, 2004 | No | Yes | Yes | RX | MYLAN IRELAND LTD | c1af0d15a667b733dc287a50cf050f9beaef023ecfedd65893feb3747e9a3d97 |
| 14948 | N | 021345 | 003 | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | INJECTABLE | SUBCUTANEOUS | ARIXTRA | MYLAN IRELAND LTD | 7.5MG/0.6ML | AP | ["AP"] | 2004-05-28 | May 28, 2004 | No | Yes | Yes | RX | MYLAN IRELAND LTD | 40cb3d51a5dbc8c8dce22020da97bd3dc1d8aae915728f293f99304fa5c03d9a |
| 14949 | N | 021345 | 004 | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | INJECTABLE | SUBCUTANEOUS | ARIXTRA | MYLAN IRELAND LTD | 10MG/0.8ML | AP | ["AP"] | 2004-05-28 | May 28, 2004 | No | Yes | Yes | RX | MYLAN IRELAND LTD | 33ac92f8f68f7b15fd65cdf851382d91a62196a2c2f6569b448b7a73d4168eca |
| 14950 | N | 021773 | 001 | EXENATIDE SYNTHETIC | INJECTABLE;SUBCUTANEOUS | INJECTABLE | SUBCUTANEOUS | BYETTA | ASTRAZENECA AB | 300MCG/1.2ML (250MCG/ML) | | [] | 2005-04-28 | Apr 28, 2005 | No | Yes | Yes | RX | ASTRAZENECA AB | 7d5f3e5d7641ca1a05199801bf250181f09438b4f508dfa7e7aedb5d592d35a6 |
| 14951 | N | 021773 | 002 | EXENATIDE SYNTHETIC | INJECTABLE;SUBCUTANEOUS | INJECTABLE | SUBCUTANEOUS | BYETTA | ASTRAZENECA AB | 600MCG/2.4ML (250MCG/ML) | | [] | 2005-04-28 | Apr 28, 2005 | No | Yes | Yes | RX | ASTRAZENECA AB | 04411037a2f652e9e36011268e233ffc8a7dd1870aecdc96e2bced28b0451655 |